Status: Recruiting
Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
Addition of postoperative chemotherapy to prevent or delay recurrence in patients newly diagnosed with localized uterine leiomyosarcoma and who have undergone complete tumor surgery.
Participants needed: 198
Trial details
Phase: Phase 2Age: 18-75Biological sex: FemaleType: InterventionalSponsor: UNICANCERUpdated: Sep 29, 2026Locations: 25
Eligibility criteria
Patient must have a histologically confirmed diagnosis of uterine leiomyosarcoma... [+20]
All other histology types of uterine sarcoma (adenosarcoma, endometrial sarcoma,... [+15]